GSK PLC (GSK)
33.96
+0.26
(+0.77%)
USD |
NYSE |
Nov 22, 16:00
34.14
+0.18
(+0.53%)
After-Hours: 20:00
GSK Free Cash Flow: 6.053B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.053B |
| June 30, 2024 | 6.479B |
| March 31, 2024 | 6.584B |
| December 31, 2023 | 5.505B |
| September 30, 2023 | 4.221B |
| June 30, 2023 | 2.782B |
| March 31, 2023 | 3.147B |
| December 31, 2022 | 6.371B |
| September 30, 2022 | 9.121B |
| June 30, 2022 | 10.25B |
| March 31, 2022 | 9.966B |
| December 31, 2021 | 7.289B |
| September 30, 2021 | 7.078B |
| June 30, 2021 | 5.642B |
| March 31, 2021 | 7.510B |
| December 31, 2020 | 8.337B |
| September 30, 2020 | 7.699B |
| June 30, 2020 | 9.742B |
| March 31, 2020 | 7.807B |
| December 31, 2019 | 7.479B |
| September 30, 2019 | 8.653B |
| June 30, 2019 | 8.233B |
| March 31, 2019 | 8.601B |
| December 31, 2018 | 8.839B |
| September 30, 2018 | 6.875B |
| Date | Value |
|---|---|
| June 30, 2018 | 6.690B |
| March 31, 2018 | 5.894B |
| December 31, 2017 | 6.089B |
| September 30, 2017 | 6.406B |
| June 30, 2017 | 6.129B |
| March 31, 2017 | 6.684B |
| December 31, 2016 | 5.616B |
| September 30, 2016 | 3.776B |
| June 30, 2016 | 2.240B |
| March 31, 2016 | 847.22M |
| December 31, 2015 | 1.021B |
| September 30, 2015 | 2.399B |
| June 30, 2015 | 3.751B |
| March 31, 2015 | 4.697B |
| December 31, 2014 | 5.646B |
| September 30, 2014 | 5.700B |
| June 30, 2014 | 6.833B |
| March 31, 2014 | 8.150B |
| December 31, 2013 | 8.638B |
| September 30, 2013 | 8.158B |
| June 30, 2013 | 4.548B |
| March 31, 2013 | 4.780B |
| December 31, 2012 | 4.524B |
| September 30, 2012 | 4.986B |
| June 30, 2012 | 8.499B |
Free Cash Flow Range, Past 5 Years
2.782B
Minimum
Jun 2023
10.25B
Maximum
Jun 2022
6.953B
Average
7.183B
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 6.757B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
| Sanofi SA | -- |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.885B |
| Cash from Investing (Quarterly) | -926.64M |
| Cash from Financing (Quarterly) | -1.718B |
| Free Cash Flow Per Share (Quarterly) | 0.8449 |
| Free Cash Flow to Equity (Quarterly) | 1.689B |
| Free Cash Flow to Firm (Quarterly) | 1.913B |
| Free Cash Flow Yield | 8.64% |